Masahiro Niikura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Masahiro Niikura has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
S.-H. Sheldon Tai
Faculty of Health Sciences, Simon Fraser University, Canada
4 shared publications- Hans H. Cheng
USDA-ARS, Avian Disease and Oncology Laboratory, East Lansing, MI 48823, USA
3 shared publications - John R. Dunn
United States Department of Agriculture, Agricultural Research Service, US National Poultry Research Center, Southeast Poultry Research Laboratory, Athens, Georgia 30605, USA
2 shared publications Olga Agafitei
Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada
2 shared publicationsSiobhan Ennis
Faculty of Health Sciences, Simon Fraser University, Canada
2 shared publications- Stephen G. Withers
Department of Chemistry University of British Columbia Vancouver British Columbia Canada
2 shared publications
Latest Publications
- 1 August 2021
- Published by Elsevier in Veterinary Microbiology
- Vol. 259, 109145
Corrigendum to “Marek’s disease virus oncogene Meq expression in infected cells in vaccinated and unvaccinated hosts” [Vet. Microbiol. 248 (2020) 108821]
- 1 August 2021
- Published by Elsevier in Veterinary Microbiology
- Vol. 259, 109145
Corrigendum to “Marek’s disease virus oncogene Meq expression in infected cells in vaccinated and unvaccinated hosts” [Vet. Microbiol. 248 (2020) 108821]
- 1 September 2020
- Published by Elsevier in Veterinary Microbiology
- Vol. 248, 108821
Marek’s disease virus oncogene Meq expression in infected cells in vaccinated and unvaccinated hosts
- 1 September 2020
- Published by Elsevier in Veterinary Microbiology
- Vol. 248, 108821
Marek’s disease virus oncogene Meq expression in infected cells in vaccinated and unvaccinated hosts
- 13 February 2017
- Published by Wiley in Angewandte Chemie
- Vol. 129 (22) , 6208-6212
Ultrasensitive Fluorogenic Reagents for Neuraminidase Titration
- 13 February 2017
- Published by Wiley in Angewandte Chemie
- Vol. 129 (22) , 6208-6212
Ultrasensitive Fluorogenic Reagents for Neuraminidase Titration
- 1 December 2015
- Published by Elsevier in Virus Research
- Vol. 210, 126-132
Difluorosialic acids, potent novel influenza virus neuraminidase inhibitors, induce fewer drug resistance-associated neuraminidase mutations than does oseltamivir
- 1 December 2015
- Published by Elsevier in Virus Research
- Vol. 210, 126-132
Difluorosialic acids, potent novel influenza virus neuraminidase inhibitors, induce fewer drug resistance-associated neuraminidase mutations than does oseltamivir
- Open Access
- 1 December 2015
- Published by Elsevier in Virology Reports
- Vol. 5, 10-18
Mutations within ICP4 acquired during in vitro attenuation do not alter virulence of recombinant Marek's disease viruses in vivo
- 1 December 2015
- Published by Elsevier in Virology Reports
- Vol. 5, 10-18
Open AccessMutations within ICP4 acquired during in vitro attenuation do not alter virulence of recombinant Marek's disease viruses in vivo
- 1 June 2011
- Published by Elsevier in Antiviral Research
- Vol. 90 (3) , 160-163
Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro
- 1 June 2011
- Published by Elsevier in Antiviral Research
- Vol. 90 (3) , 160-163
Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro
- 1 December 2010
- Published by Microbiology Society in Journal of General Virology
- Vol. 92 (3) , 598-607
Virulent Marek's disease virus generated from infectious bacterial artificial chromosome clones with complete DNA sequence and the implication of viral genetic homogeneity in pathogenesis
Genetic homogeneity of a test population is essential to precisely associate a viral genome sequence and its phenotype at the nucleotide level. However, homogeneity is not easy to achieve for Marek's disease virus (MDV) due to its strictly cell-associated replication. To address this problem, two virulent infectious bacterial artificial chromosome (BAC) clones of MDV were generated from an MDV genome previously cloned as five overlapping cosmids. The Md5SN5BAC clone has the BAC vector inserted between the 3' ends of UL3 and UL4, such that no known ORFs should be disrupted. The BAC vector is flanked by loxP sites, so that it can be deleted from the viral genome by transfecting Md5SN5BAC into a newly developed chicken cell line that constitutively expresses Cre recombinase. The Md5B40BAC clone has the BAC vector replacing a portion of US2, a location similar to that used by other groups to construct MDV-BAC clones. Although both BACs were capable of producing infectious virulent MDV when inoculated into susceptible chickens, Md5B40BAC-derived viruses showed somewhat better replication in vivo and higher virulence. Removal of the BAC vector in Md5SN5BAC-derived viruses had no influence on virulence. Interestingly, when genetically homogeneous virulent MDV generated from Md5B40BAC was mixed with avirulent virus, the overall virulence of the mixed population was noticeably compromised, which emphasizes the importance of MDV population complexity in pathogenesis.
- 1 December 2010
- Published by Microbiology Society in Journal of General Virology
- Vol. 92 (3) , 598-607
Virulent Marek's disease virus generated from infectious bacterial artificial chromosome clones with complete DNA sequence and the implication of viral genetic homogeneity in pathogenesis
Genetic homogeneity of a test population is essential to precisely associate a viral genome sequence and its phenotype at the nucleotide level. However, homogeneity is not easy to achieve for Marek's disease virus (MDV) due to its strictly cell-associated replication. To address this problem, two virulent infectious bacterial artificial chromosome (BAC) clones of MDV were generated from an MDV genome previously cloned as five overlapping cosmids. The Md5SN5BAC clone has the BAC vector inserted between the 3' ends of UL3 and UL4, such that no known ORFs should be disrupted. The BAC vector is flanked by loxP sites, so that it can be deleted from the viral genome by transfecting Md5SN5BAC into a newly developed chicken cell line that constitutively expresses Cre recombinase. The Md5B40BAC clone has the BAC vector replacing a portion of US2, a location similar to that used by other groups to construct MDV-BAC clones. Although both BACs were capable of producing infectious virulent MDV when inoculated into susceptible chickens, Md5B40BAC-derived viruses showed somewhat better replication in vivo and higher virulence. Removal of the BAC vector in Md5SN5BAC-derived viruses had no influence on virulence. Interestingly, when genetically homogeneous virulent MDV generated from Md5B40BAC was mixed with avirulent virus, the overall virulence of the mixed population was noticeably compromised, which emphasizes the importance of MDV population complexity in pathogenesis.